FDA Warning Letter — Samchundang Pharm Co., Ltd.
The FDA took a Warning Letter action against Samchundang Pharm Co., Ltd. on May 13, 2020 (Hwaseong, South Korea). The action was issued by CDER and concerns drugs products. This facility has 3 recent FDA inspections on record.
Action Details
- Facility
- Samchundang Pharm Co., Ltd.
- Date
- May 13, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Center
- CDER
- Location
- Hwaseong (South Korea)